Evidence map›Paper›PMID 35203447›Full record

ArticleBiomedicines2022

Profiling Microglia in a Mouse Model of Machado-Joseph Disease.

Ana Bela Campos, Sara Duarte-Silva, Bruno Fernandes, Sofia Pereira das Neves, Fernanda Marques, Andreia Teixeira-Castro, Andreia Neves-Carvalho, Daniela Monteiro-Fernandes, Camila Cabral Portugal, Renato Socodato and 4 more

Abstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IPInternational journal of molecular sciences · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ana Bela CamposLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Sara Duarte-SilvaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Bruno FernandesDepartment of Informatics, ALGORITMI Center, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0003-1561-2897
Sofia Pereira das NevesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Fernanda MarquesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-3612-1870
Andreia Teixeira-CastroLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0003-4999-5996
Andreia Neves-CarvalhoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Daniela Monteiro-FernandesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Camila Cabral PortugalGlial Cell Biology Group, Instituto de Investigação e Inovação em Saúde (i3S), Instituto de Biologia Molecular e Celular (IBMC), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-1093-6545
Renato SocodatoGlial Cell Biology Group, Instituto de Investigação e Inovação em Saúde (i3S), Instituto de Biologia Molecular e Celular (IBMC), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-6882-5020
Teresa SummavielleAddiction Biology Group, Instituto de Investigação e Inovação em Saúde (i3S), Instituto de Biologia Molecular e Celular (IBMC), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0003-2548-6281
António Francisco AmbrósioCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Univiversity of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0002-0477-1641
João Bettencourt RelvasGlial Cell Biology Group, Instituto de Investigação e Inovação em Saúde (i3S), Instituto de Biologia Molecular e Celular (IBMC), University of Porto, 4200-135 Porto, Portugal.
Patrícia MacielLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-0920-6350

Funding

COMPETE-FEDER POCI-01-0145-FEDER-016818COMPETE-FEDER POCI-01-0145- FEDER-030647Fundação para a Ciência e Tecnologia PD/BD/114120/2015Fundação para a Ciência e Tecnologia PD/BD/127828/2016Fundação para a Ciência e Tecnologia PTDC/MED-NEU/31318/2017Fundação para a Ciência e Tecnologia PTDC/NEU-NMC/3648/2014Fundação para a Ciência e Tecnologia UIDB/50026/2020Fundação para a Ciência e Tecnologia UIDP/50026/2020Portuguese Platform of Bioimaging PPBI-POCI-01-0145-FEDER-022122
6 · The paper itself

Abstract

Microglia have been increasingly implicated in neurodegenerative diseases (NDs), and specific disease associated microglia (DAM) profiles have been defined for several of these NDs. Yet, the microglial profile in Machado-Joseph disease (MJD) remains unexplored. Here, we characterized the profile of microglia in the CMVMJD135 mouse model of MJD. This characterization was performed using primary microglial cultures and microglial cells obtained from disease-relevant brain regions of neonatal and adult CMVMJD135 mice, respectively. Machine learning models were implemented to identify potential clusters of microglia based on their morphological features, and an RNA-sequencing analysis was performed to identify molecular perturbations and potential therapeutic targets. Our findings reveal morphological alterations that point to an increased activation state of microglia in CMVMJD135 mice and a disease-specific transcriptional profile of MJD microglia, encompassing a total of 101 differentially expressed genes, with enrichment in molecular pathways related to oxidative stress, immune response, cell proliferation, cell death, and lipid metabolism. Overall, these results allowed us to define the cellular and molecular profile of MJD-associated microglia and to identify genes and pathways that might represent potential therapeutic targets for this disorder.

Indexed as

cell morphologyMachado–Joseph diseasemachine learningmicrogliaRNA-sequencing

Identifiers

PMID35203447
PMCPMC8869404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.